postherpetic neuralgia
Conditions
Interventions
case group:NA
control group:NA
Sponsors
Nanjing Drum Tower Hospital The Affiliated Hospital Of Nanjing University Medical School
Eligibility
Sex/Gender
All
Age
50 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients with acute herpes zoster, duration of disease within 30 days; 2. The patient intends to receive comprehensive treatment including drugs, injection therapy and radiofrequency therapy; 3. over 50 years old 4. Consent to participate in the clinical study. Willing to provide blood, urine and cerebrospinal fluid samples.
Exclusion criteria
Exclusion criteria: 1. Contraindications of minimally invasive interventional therapy such as infection and coagulation function, or conventional comprehensive treatment is not acceptable for participant; 2. central nervous system diseases; 3. Severe immunosuppressive diseases such as leukemia and lymphoma; 4. Patients taking long-term glucocorticoid therapy or immunosuppressive therapy; 5. have received intrathecal drug injection within 3 months; 6. pregnant women; 7. Unable to complete the questionnaire and follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Occurrence of postherpetic neuralgia;Differential Proteins; | — |
Countries
china
Contacts
Public ContactYing Han
Nanjing Drum Tower Hospital The Affiliated Hospital Of Nanjing University Medical School
Outcome results
None listed